Digital Sponsored One assistant to rule them all? Why the future of work is pl... How many tools do you usually use at work? One to two, or is it closer to five or six?
Digital Boosting trust in AI: The essential foundation for breakthro... The use of artificial intelligence (AI) in healthcare is growing rapidly and already providing patients with better care and support.
Digital From pilots to impact: What it really takes to scale GenAI i... Just a year ago, the GenAI buzz in pharma felt like the start of a gold rush. Leaders greenlit pilots. Teams spun up proof-of-concepts.
Digital BIO 2025: As pharma deploys AI across the value chain, data ... At BIO 2025 in Boston today, pharma and biotech leaders discussed the current state of AI in the drug development life cycle.
Digital Everyday drug discovery: How tech expands the potential of c... Discover how technology is making clinical trials more flexible and patient-friendly through tools like eCOA, eConsent, and wearables.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
